NeuroFlow
NeuroFlow is a behavioral health analytics and engagement platform for payers, health systems, and federal agencies that need to surface hidden risk, route members to care, and measure outcomes at population scale.

Heartflow provides non-invasive, personalized cardiac testing to improve the diagnosis and management of coronary artery disease.
Heartflow offers a non-invasive approach to diagnosing and managing coronary artery disease (CAD), a condition that remains a leading cause of death worldwide. The company's platform, known as the Heartflow Analysis, combines anatomical and functional data from a standard coronary CT angiogram to help clinicians assess the severity of CAD without the need for invasive procedures. This technology is designed for cardiologists, radiologists, and healthcare systems looking to improve patient outcomes and reduce unnecessary testing.
Conventional diagnostic methods for CAD often provide incomplete or misleading information, which can lead to undiagnosed disease, unnecessary procedures, incorrect treatment plans, and increased costs. Heartflow aims to address these gaps by offering a more comprehensive, personalized assessment that supports better clinical decision-making.
The Heartflow Analysis includes several components: FFR CT Analysis, Roadmap Analysis, and Plaque Analysis. FFR CT Analysis calculates fractional flow reserve from CT images, providing insight into the functional significance of coronary blockages. Roadmap Analysis creates a personalized 3D model of the coronary arteries to aid in procedural planning. Plaque Analysis quantifies and characterizes plaque burden, which can inform risk assessment and treatment strategies. Together, these tools offer a multifaceted view of a patient's coronary health.
The PCI Navigator tool is part of the Heartflow offering, designed to assist interventional cardiologists in planning percutaneous coronary intervention (PCI) procedures. By integrating data from the Heartflow Analysis, it helps clinicians determine the optimal approach for stent placement and other interventions, potentially improving procedural outcomes.
The Heartflow Analysis is commercially available in the United States, with specific functionalities also available in the European Union, United Kingdom, Japan, Canada, and other select regions. The company holds ISO 13485 certification for quality management of medical devices and SOC certification, indicating adherence to rigorous standards for data security and quality.
Heartflow Analysis is intended to be used in conjunction with a patient's clinical history, symptoms, and other diagnostic data, as well as the clinician's professional judgment. It may not be appropriate for all patients, and clinicians should consult the Indications for Use and safety information for additional details. The information provided by Heartflow Analysis is not a substitute for clinical expertise but rather a tool to enhance it.
Heartflow's stated vision is to transform CAD from the leading cause of death into a disease that can be managed for life. By providing non-invasive, actionable insights, the company seeks to shift the paradigm of CAD management toward earlier detection, more precise treatment, and improved long-term patient care. This vision aligns with broader trends in healthcare toward personalized, data-driven approaches that prioritize patient safety and outcomes.
Subscription pricing is not listed.
Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →
NeuroFlow is a behavioral health analytics and engagement platform for payers, health systems, and federal agencies that need to surface hidden risk, route members to care, and measure outcomes at population scale.
Buoy Health uses AI conversations to help users comb through symptoms, narrow down possible causes, and guide them to the right direction. The content is written and reviewed by the clinician with an emphasis on being clear and actionable rather than creating panic.
Ada is a clinician-optimized AI symptom assessment tool that helps users understand their health while providing patient triage and touch solutions to enterprise partners.
Nabla is a clinical AI layer that captures patient-clinician conversations and generates structured notes, dictation, and coding suggestions inside Epic and major EHRs.